The risk of epilepsy in children with celiac disease: a population-based cohort study

C Canova1, J F Ludvigsson2,3,4,5, C Barbiellini Amidei1

  • 1Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Insights

Individuals with celiac disease (CD) face a doubled risk of epilepsy, even before diagnosis. Early screening for CD in epilepsy patients may improve treatment outcomes.

Area of Science:

  • Neurology
  • Gastroenterology
  • Epidemiology

Background:

  • Celiac disease (CD) is an autoimmune disorder.
  • The association between CD and neurological conditions like epilepsy is increasingly recognized.
  • Understanding the temporal relationship between CD and epilepsy is crucial for patient management.

Purpose of the Study:

  • To investigate the risk of epilepsy in young individuals diagnosed with celiac disease.
  • To compare epilepsy incidence in CD patients versus age- and sex-matched controls.
  • To explore epilepsy risk before and after CD diagnosis.

Main Methods:

  • A cohort study of 213,635 individuals in Italy (1989-2011).
  • Identified 1,215 CD patients and 6,075 matched controls.
  • Used conditional logistic and Cox regression to analyze epilepsy risk (ORs, HRs).

Main Results:

  • Individuals with CD had a significantly higher risk of epilepsy (adjusted OR 2.03).
  • Increased epilepsy risk was observed both before CD diagnosis (OR 2.29) and after (HR 1.96).
  • Female individuals with CD showed a particularly elevated risk of epilepsy.

Conclusions:

  • Young individuals with celiac disease have an increased risk of developing epilepsy.
  • Screening for CD in patients with unexplained epilepsy is recommended.
  • Early CD diagnosis and treatment may enhance epilepsy management.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
818
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
645